INTRODUCTION
The Australian Controlled Release Society is excited to announce the Drug Delivery Australia (DDA) Conference, taking place on 17–18 November 2025 at the stunning Intercontinental Hotel Double Bay, Sydney. This annual conference will provide an inspiring setting for in-depth discussions and networking among experts in drug delivery, biomaterials, nanomedicine, and pharmaceutical sciences.
DDA 2025 will offer a dynamic platform for PhD students and EMCRs to showcase their research to both Australian and international audiences. With a program featuring cutting-edge presentations, networking sessions, and industry engagement, this conference is the ideal opportunity to foster new collaborations and drive innovation in drug delivery science.
We very much look forward to a vibrant in-person conference and would value your support to power this a great event.
Come join us in Sydney for an exciting DDA2025 meeting and beautiful harbourside views!
Key Details
| Abstract Submission Deadline | 31st August 2025 |
| Early Bird Registrations Deadline | 14th September 2025 |
| Abstract Outcome Notification | 21st September – 5th October 2025 |
*Registration form to open soon
Registration Costs
| Type | Early Bird Registration (by 14th September 2025) | Late Registration (15th September 2025 onwards) |
| Student | AUD 400 | AUD 450 |
| Staff | AUD 500 | AUD 550 |
| Industry | AUD 600 | AUD 650 |
Day registration for all attendees is AUD250
Organising Committee
(Abstracts coordinator)
(Program Coordinator)
(Sponsorships Coordinator)
Sponsorship Details
DDA 2025 meeting will be held on 17–18 November 2025 at the Intercontinental Hotel, Double Bay, Sydney, New South Wales.
The event will bring together world-leading scientists, mid-career and early career researchers, engineers and leaders from academia and industry working in the field of drug delivery and formulation engineering to discuss new and exciting advances in this dynamic field of research.
The theme of this year’s DDA meeting is “Biomaterials meet Drug Delivery: New Horizons in Medicine” and your company’s products and interests would fit perfectly within our theme.
This meeting is expected to attract ~200 attendees (>80% from Australia
and New Zealand region).
We would like to offer you an opportunity to put your organisations brand in front of key research professionals, who have a great interest in Drug Delivery, Biomaterials, and Pharmaceutics, by becoming a meeting sponsor.